Parallax Volatility Advisers
GTHX

Parallax Volatility Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Parallax Volatility Advisers’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,000
Closed -$66K – 3950
2019
Q1 		$66K Buy
+4,000
New +$75.9K ﹤0.01% 2214
2018
Q1 		– Sell
-1,176
Closed -$23K – 4561
2017
Q4 		$23K Buy
+1,176
New +$25.3K ﹤0.01% 3626

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Parallax Volatility Advisers's GTHX Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2019, closing a stake of 4,000 shares — an estimated $66K sold.

Parallax Volatility Advisers first reported a position in GTHX in Q4 2017 and held it in 2 quarters. The position peaked at $66K in Q1 2019. 94 funds tracked by Wall St. Rank hold GTHX as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,000 G1 Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $66K.
  • Parallax Volatility Advisers first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's G1 Therapeutics, Inc. Common Stock position peaked at $66K in Q1 2019.
  • 94 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.